Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-19-026848
Filing Date
2019-12-23
Accepted
2019-12-23 16:51:44
Documents
1
Period of Report
2019-12-19

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3944
  Complete submission text file 0001213900-19-026848.txt   5336
Mailing Address 880 3RD AVENUE, 12TH FLOOR NEW YORK NY 10022
Business Address 880 3RD AVENUE, 12TH FLOOR NEW YORK NY 10022 646 876 3459
RELMADA THERAPEUTICS, INC. (Issuer) CIK: 0001553643 (see all company filings)

EIN.: 455401931 | State of Incorp.: NV | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address 305 WEST 18TH STREET, APT 4B NEW YORK NY 10011
Business Address
Shenouda Maged (Reporting) CIK: 0001658369 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39082 | Film No.: 191306793